Delivery Order SPE2DB24D8001-SPE2DB24FKYYT

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $4.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,762.80, is a firm fixed-price delivery order for the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The award, valued at $3,457.84, is a delivery order under the company's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which is part of the DLA Troop Support Medical's ECAT Generation V Program. This...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $15,860.63, is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of March 20, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
This contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, is a firm fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of pharmaceutical products, including prescription medications such as insulin pens, inhalers, anticoagulants, and biologic drugs. The contract, valued at $11,449.29, has an ultimate completion date of September 4, 2024 and is not designated as a set-aside contract. Dakota Drug, Inc. holds a...
This is a federal contract award by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract has an award value of $1,193.01 and a completion date of February 7, 2024. This award is not associated with a set-aside program and is a firm fixed-price delivery order contract. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,738.12 contract is for the delivery of AREXVY VIAL KITS, with a period of performance through October 28, 2024. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide a variety of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract, identified as SPE2DX15D8002|SPE2DX24F2UW2, has a ceiling value of $4,825.71 and is a Firm Fixed Price Delivery Order with a completion date of February 9, 2024. Dakota Drug, Inc. is a key supplier...
This contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The award, valued at $1,179.40, is a Firm Fixed Price Delivery Order against the company's existing Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which has a ceiling value of $999,999,999.00. This IDC is part of the DLA Troop Support...
This federal contract award, valued at $6,467.31, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a firm fixed-price delivery order for the provision of 4565365894 ! YUVAFEM 10 MCG VAGINAL INSERT 18S. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which enables the...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical division, awarded a Firm Fixed Price delivery order contract valued at $4,787.60 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of SKYLA 13.5 MG SYSTEMS medical supplies, with a performance period extending through April 25, 2024. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified...
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB24FKYYT
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,881.94 to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, which does not have a set-aside designation, is for the delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of August 27, 2024.

Generated 11/25/24, 9:11 AM